Yayınlar & Eserler

Yayın Ağı
Makaleler 153
Tümü (153)
SCI-E, SSCI, AHCI (127)
SCI-E, SSCI, AHCI, ESCI (138)
ESCI (9)
Scopus (130)
TRDizin (15)
Diğer Yayınlar (5)

1. Evaluation of clinical pharmacy services in patients receiving antithrombotic treatment in a randomized controlled trial

Sosyal D., BEKTAY M. Y., AÇIKGÖZ N., İZZETTİN F. V.
Scientific Reports , cilt.15, sa.1, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

2. Assessing medication discrepancies in pediatric patients: a cross-sectional feasibility study using the Medication Discrepancy Taxonomy (MedTax) in a pediatric ward

MERCÜMEK B., BEKTAY M. Y., UZUNER S., İZZETTİN F. V.
BMC Pediatrics , cilt.25, sa.1, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

3. Impact of clinical pharmacist integration on diabetes management: a prospective cohort.

Kutluay N. B., Bektay M. Y., Sumbul-Sekerci B., Sekerci A., Izzettin F. V.
BMC health services research , cilt.25, sa.1, ss.107, 2025 (SCI-Expanded, Scopus) identifier

4. PREVALENCE AND INFLUENCING FACTORS OF SELF-MEDICATION WITH ANALGESICS AMONG ADULTS: AN OBSERVATIONAL STUDY

Bektay M. Y., Mercümek B., Koroglu F. N., İzzettin F. V.
FARMACIA , sa.6, ss.1450-1459, 2024 (SCI-Expanded, Scopus) identifier

5. Foreword

İZZETTİN F. V.
The Roles and Responsibilities of Clinical Pharmacists in Hospital Settings , 2024 (Scopus) identifier

6. Pharmacists’s knowledge, attitude, and practices towards pharmaceutical and patient-centred care in asthma management: A national study

Çakmak D., Yunus Bektay M., Al-Taie A., Ahmed Ali Jadoo S., Vehbi Izzettin F. V.
SAUDI PHARMACEUTICAL JOURNAL , ss.1-9, 2024 (SCI-Expanded, Scopus)

7. Impact of structured patient education provided by clinical pharmacist on disease prognosis, adherence and quality of life in type 2 diabetes patients: an interventional study

Demirhan Ş., Bektay M. Y., Şekerci A., İzzettin F. V.
ACTA PHARMACEUTICA SCIENCIA , cilt.62, sa.3, ss.660-677, 2024 (Scopus)

8. An Assessment of Different Decision Support Software from the Perspective of Potential Drug–Drug Interactions in Patients with Chronic Kidney Diseases

Bektay M. Y., Buker Cakir A., Gursu M., Kazancioglu R., Izzettin F. V.
PHARMACEUTICALS , cilt.17, sa.5, ss.1-19, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

9. Evaluation of Pharmacist Contribution to Adherence and Illness Perception in Hypertension: An Observational Study

Guruhan E., Bektay M. Y., Yılmaz Z., İzzettin F. V.
ANATOLIAN CLINIC JOURNAL OF MEDICAL SCIENCES , cilt.28, sa.3, ss.372-381, 2023 (TRDizin) Sürdürülebilir Kalkınma identifier

10. PHARMACIST-LED ASSESSMENT OF ANXIETY LEVELS AND ASSOCIATED FACTORS: A PROSPECTIVE OBSERVATIONAL SURVEY

Bektay M. Y., Tütüncü B., Sosyal D., Atak M., İzzettin F. V.
ANKARA UNIVERSITESI ECZACILIK FAKULTESI DERGISI , cilt.47, sa.3, ss.944-956, 2023 (Scopus, TRDizin) Sürdürülebilir Kalkınma identifier identifier

11. Comparison of different decision support software programs in perspective of potential drug-drug interactions in the oncology clinic

Bektay M. Y., Şeker Z., Eke H. K., Türk H. M., İzzettin F. V.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.29, sa.5, ss.1178-1186, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

12. Determination of the Plasma Levels of Growth Arrest Specific 6 in Colon Cancer Patients

tezcan s., izzettin f. v., Bingöl Özakpınar Ö., Attaallah W., Yumuk P. F., uras f.
Clinical and Experimental Health Sciences , cilt.13, sa.2, ss.400-403, 2023 (ESCI, TRDizin) Creative Commons License identifier identifier

13. Investigation of drug-related problems in patients hospitalized in chest disease wards: A randomized controlled trial

Bektay M. Y., Sancar M., Okyaltirik F., Durdu B., Izzettin F. V.
Frontiers in Pharmacology , cilt.13, 2023 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier identifier

14. Identification of Drug-Related Problems and Investigation of Related Factors in Patients with COVID-19: An Observational Study

Bektay M. Y., Sancar M., Okyaltırık F., Durdu B., İzzettin F. V.
BEZMIALEM SCIENCE , cilt.10, sa.6, ss.777-785, 2022 (ESCI, TRDizin) Sürdürülebilir Kalkınma identifier identifier identifier

15. Evaluation of medication dose adjustments in patients with impaired renal function using different online drug information databases.

Sancar M., Altiparmak O., Altan A., Demirtunc R., Izzettin F. V., Okuyan B.
European journal of hospital pharmacy : science and practice , cilt.29, sa.5, ss.255-258, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

16. Therapeutic Drug Monitoring in Pediatric Patients Treated with Anti-Tuberculosis Medications by High Performance Liquid Chromatography

OKUYAN B., TOK F., KARAKUŞ S., Dalgiç N., ÇAKIR E., Midyat L., et al.
Journal of Research in Pharmacy , cilt.26, sa.6, ss.1907-1914, 2022 (Scopus, TRDizin) identifier identifier identifier

17. Investigation of potential drug-drug interaction in chronic kidney disease patients in nephrology clinic

Buker A., SOSYAL D., ÖZMEN Ö., BEKTAY M. Y., GÜRSU M., KAZANCIOĞLU R., et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.43, sa.6, ss.1778, 2021 (SCI-Expanded, Scopus) identifier

18. Investigation of pharmaceutical care need of COVID-19 patients in hospital settings

Bektay M. Y., Sancar M., Okyaltırık F., Durdu B., İzzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.43, sa.6, ss.1777-1778, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

19. Attitudes of medicine, pharmacy, and dentistry students about psychostimulant use to enhance cognition.

Sümbül-Şekerci B., Bildik Ö., Bektay M. Y., İzzettin F. V.
International journal of clinical practice , cilt.75, sa.10, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

20. Adaptation of Chronic Kidney Disease-Self Management Knowledge Tool (CKD-SMKT) into Turkish

Altiparmak O., İZZETTİN F. V., OKUYAN B., ARIKAN İ. H., SANCAR M.
CLINICAL AND EXPERIMENTAL HEALTH SCIENCES , cilt.11, sa.3, ss.432-436, 2021 (ESCI, TRDizin) Creative Commons License identifier identifier

21. Insight into Turkish Community Pharmacists' Services in the First Wave of the COVID-19 Pandemic.

Bektay M. Y., Okuyan B., Sancar M., Izzettin F. V.
Disaster medicine and public health preparedness , sa.3, ss.1-4, 2021 (SCI-Expanded, SSCI, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

22. Investigation of DNA damage, oxidative stress, and inflammation in synthetic cannabinoid users.

Guler E. M., Bektay M. Y., Akyildiz A., Sisman B., Izzettin F. V., Kocyigit A.
Human & experimental toxicology , cilt.39, ss.1454-1462, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

23. Treatment of coronavirus disease 2019: a comprehensive review

Sosyal D., Özmen Ö., Bektay M. Y., İzzettin F. V.
Journal of Ideas in Health , cilt.3, sa.4, ss.228-242, 2020 (Hakemli Dergi) Sürdürülebilir Kalkınma

24. Impact of clinical pharmacy recommendations and patient counselling program among patients with diabetes and cancer in outpatient oncology setting.

Al-Taie A., Izzettin F. V., Sancar M., Köseoğlu A.
European journal of cancer care , cilt.29, 2020 (SCI-Expanded, SSCI, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

25. Impact of verbal and web-based patient education programs driven by clinical pharmacist on the adherence and illness perception of hypertensive patients

YILMAZ Z., SANCAR M., OKUYAN B., YEŞİLDAĞ O., İzzettin F. V.
Indian Journal of Pharmaceutical Education and Research , cilt.54, sa.3, 2020 (SCI-Expanded, Scopus) identifier identifier

26. Time to change to improve health: clinical pharmacy and pharmaceutical care education in Turkey

Bektay M. Y., Sancar M., Al-Ezzı S. A. A., Izzettin F. V.
Journal of Ideas in Health , cilt.3, sa.1, ss.130-134, 2020 (Hakemli Dergi) Creative Commons License

27. Evaluation of medication regimen complexity and medication adherence in patients with Benign Prostatic Hyperplasia

Algorane I., OKUYAN B., SANCAR M., İZZETTİN F. V., ÇAM H. K.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.42, sa.1, ss.249, 2020 (SCI-Expanded, Scopus) identifier

28. Evaluation of parents' knowledge and attitude about antipyretics

Bahadur A., İZZETTİN F. V., ŞAHİN Y., OKUYAN B., SANCAR M.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.42, sa.1, ss.238, 2020 (SCI-Expanded, Scopus) identifier

29. Evaluation of the quality of life, attitudes and perceptions in patients with benign prostatic hyperplasia

İZZETTİN F. V., Algorane I., OKUYAN B., SANCAR M., ÇAM H. K.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.42, sa.1, ss.235-236, 2020 (SCI-Expanded, Scopus) identifier

30. Comparision of different decision support software programs in perspective of potential drug-drug interactions in oncology clinic

BEKTAY M. Y., Seker Z., Eke H. K., TÜRK H. M., İZZETTİN F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.42, sa.1, ss.229, 2020 (SCI-Expanded, Scopus) identifier

31. Evaluation of potentially inappropriate medication utilization in elderly patients with cancer at outpatient oncology unit.

Paksoy C., Özkan Ö., Ustaalioğlu B., Sancar M., Demirtunç R., Izzettin F. V., et al.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , cilt.25, ss.1321-1327, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

32. Determination of Potential Drug-Drug Interactions Using Various Software Programs in a Community Pharmacy Setting

SANCAR M., Kasik A., OKUYAN B., Batuhan S., Izzettin F. V.
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.16, sa.1, ss.14-19, 2019 (ESCI, Scopus, TRDizin) Creative Commons License identifier identifier identifier

33. Evaluation of knowledge and attitudes of patients and pharmacists on using herbal products

TEZCAN S., Kizilkaya M., SANCAR M., Izzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.41, sa.1, ss.329, 2019 (SCI-Expanded, Scopus) identifier

34. Evaluation of satisfaction and internet self-efficacy of inquirers using an internet-based drug information centre

Izzettin F. V., YILMAZ Z., OKUYAN B., SANCAR M.
JOURNAL OF TAIBAH UNIVERSITY MEDICAL SCIENCES , cilt.14, sa.1, ss.67-72, 2019 (ESCI, Scopus) identifier identifier identifier

35. Assessment of individuals' knowledge and attitudes towards utilization of analgesics at community pharmacy setting

Torun B., ÖZKAN O. C., Zortul H., Kesedar S., Izzettin F. V., SANCAR M., et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.41, sa.1, ss.327-328, 2019 (SCI-Expanded, Scopus) identifier

36. Determination of patients' knowledge about Helicobacter pylori treatment and evaluate consistency of their Helicobacter pylori treatment regimen with the guidelines

Yesilbursa Y., ŞAHİN Y., OKUYAN B., Izzettin F. V., SANCAR M.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.41, sa.1, ss.379, 2019 (SCI-Expanded, Scopus) identifier

37. Determination of knowledge and attitudes of community pharmacists towards probiotics

Poyraz N., OKUYAN B., Cengiz K. N., Izzettin F. V., SANCAR M.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.41, sa.1, ss.329, 2019 (SCI-Expanded, Scopus) identifier

38. Determination of the knowledge of the participants regarding probiotics purchased from community pharmacy

Yildiz D., Cengiz K. N., OKUYAN B., Izzettin F. V., SANCAR M.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.41, sa.1, ss.368, 2019 (SCI-Expanded, Scopus) identifier

39. The role of the clinical pharmacist in patient education and monitoring of patients under warfarin treatment

İZZETTİN F. V., Celik S., Acar R. D., TEZCAN S., Aksoy N., BEKTAY M. Y., et al.
JOURNAL OF RESEARCH IN PHARMACY , cilt.23, sa.6, ss.1157-1163, 2019 (ESCI, Scopus, TRDizin) Creative Commons License identifier identifier

40. Comparison of conditioning regimen toxicities among autologous stem cell transplantation eligible multiple myeloma patients: High-dose melphalan versus high-dose melphalan and bortezomib

Aypar E., Izzettin F. V., Aki S. Z., SANCAR M., Yegin Z. A., Turkoz-Sucak G.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.24, sa.4, ss.281-289, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

41. Role of clinical oncology pharmacist in determination of pharmaceutical care needs in patients with colorectal cancer

TEZCAN S., Izzettin F. V., SANCAR M., TURHAL N. S., YUMUK P. F.
EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE , cilt.25, 2018 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

42. The role of clinical pharmacist in evaluation of cardiometabolic risk and drug-related problems in patients with bipolar disorder

Yang S., OKUYAN B., SANCAR M., Bingol-Ozakpinar O., NEBIOGLU M., CALISKAN M., et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.40, sa.1, ss.273, 2018 (SCI-Expanded, Scopus) identifier

43. Evaluation of Pharmacists' Role Related to Corticosteroid Usage: Corticophobia

Izzettin F. V., TEZCAN S., Cakici G., ŞAHİN Y., SANCAR M.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.40, sa.1, ss.243, 2018 (SCI-Expanded, Scopus) identifier

44. Medication errors facing the hospitalized cardiovascular disease patients

Sizgen F., Apikoglu-Rabus S., Izzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.40, sa.1, ss.246, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

45. Importance of medication dose adjustment in hospitalized patients with impaired renal function at internal medicine ward: the possible impact of clinical pharmacist

Altan A., Ozkan O., DEMIRTUNC R., OKUYAN B., Izzettin F. V., SANCAR M.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.40, sa.1, ss.275, 2018 (SCI-Expanded, Scopus) identifier

46. Evaluation of the different patient education methods given by the clinical pharmacist

Yilmaz Z. K., SANCAR M., OKUYAN B., YEŞİLDAĞ O., Izzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.40, sa.1, ss.243-244, 2018 (SCI-Expanded, Scopus) identifier

47. Medication adherence and medication regimen complexity of patients with polypharmacy at community pharmacy setting

Leblebici A., Torun B., Ozkan O., Ozdemir B., Belentepe A., Ince I., et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.40, sa.1, ss.237, 2018 (SCI-Expanded, Scopus) identifier

48. Protective effect of ferulic acid on cisplatin induced nephrotoxicity in rats

Bami E., Ozakpinar O. B., Ozdemir-Kumral Z. N., Koroglu K., ERCAN F., CIRAKLI Z., et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY , cilt.54, ss.105-111, 2017 (SCI-Expanded, Scopus) identifier identifier identifier

49. ASSESSMENT OF URINARY 8-HYDROXYDEOXYGUANOSINE LEVEL IN DIABETIC CANCER PATIENTS

Al-Taie A., Izzettin F. V., SANCAR M., KOSEOGLU A., ALIUSTAOGLU M., KAPTANAGASI A.
INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH , cilt.8, sa.4, ss.1619-1623, 2017 (Hakemli Dergi) Creative Commons License Sürdürülebilir Kalkınma identifier

50. Assessment of port-catheter complications in cancer patients: impact of clinical pharmacist care

KOSEOGLU A., Al-Taie A. H., ALIUSTAOGLU M., SANCAR M., Izzettin F.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.39, sa.1, ss.263, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

51. The evaluation of elderly patients' medication profile at community pharmacy setting

OKUYAN B., Atakul N., Ozkan O., Izzettin F. V., SANCAR M.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.39, sa.1, ss.248, 2017 (SCI-Expanded, Scopus) identifier

52. Drug-drug interactions identified for cardiac transplant recipients

Apikoglu-Rabus S., RABUS M. B., Ozkan O., ŞAHİN Y., Izzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.39, sa.1, ss.264, 2017 (SCI-Expanded, Scopus) identifier

53. Impact of patient education on glycemic control, medication knowledge level and medication adherence of patients with type 2 diabetes

Apikoglu-Rabus S., Sero M., OKUYAN B., Izzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.39, sa.1, ss.264-265, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

54. Evaluation of rational antibiotic dispensing in the community pharmacy setting: a simulated patient study

OKUYAN B., Savan M. A., Izzettin F. V., SANCAR M.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.39, sa.1, ss.246-247, 2017 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

55. Type 2 diabetes risk assessment program for children and adolescents at the community pharmacy setting

Apikoglu-Rabus S., Kocberber E. K., Izzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.39, sa.1, ss.318-319, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

56. Impact of a pharmaceutical care program on glycemic control, medication knowledge and medication adherence levels of type 2 diabetic patients residing at a nursing home

Saglam N., Apikoglu-Rabus S., OKUYAN B., Izzettin F. V., Yildirim N.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.39, sa.1, ss.265, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

57. Investigation of medication profile of patients during hospital admission

Odabasi G., OKUYAN B., SANCAR M., Izzettin F. V., DEMIRTUNC R.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.39, sa.1, ss.298, 2017 (SCI-Expanded, Scopus) identifier

58. Influence of Pharmacist Recommendations for Chemotherapy-Related Problems in Diabetic Cancer Patients

Izzettin F. V., Al-taie A., SANCAR M., ALIUSTAOGLU M.
MARMARA PHARMACEUTICAL JOURNAL , cilt.21, sa.3, ss.603-611, 2017 (ESCI, TRDizin) Creative Commons License Sürdürülebilir Kalkınma identifier

59. Determination of side effects and medication adherence in major depression patients utilized antidepressants

SANCAR M., Duzgun E., OKUYAN B., Deniz S., CALISKAN M., COSKUN K., et al.
MARMARA PHARMACEUTICAL JOURNAL , cilt.21, sa.1, ss.177-182, 2017 (ESCI, Scopus, TRDizin) Creative Commons License identifier identifier

60. Ethanol extract of Cotinus coggygria leaves accelerates wound healing process in diabetic rats

AKSOY H., ŞEN A., SANCAR M., ŞEKERLER T., AKAKIN D., BİTİŞ L., et al.
PHARMACEUTICAL BIOLOGY , cilt.54, sa.11, ss.2732-2736, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

61. Drug-related problems and pharmacist interventions in a cohort of patients with asthma and chronic obstructive pulmonary disease

Apikoglu-Rabus S., Yesilyaprak G., Izzettin F. V.
RESPIRATORY MEDICINE , cilt.120, ss.109-115, 2016 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

62. Validation of the Turkish version of medication regimen complexity index among elderly patients

OKUYAN B., Babi B., SANCAR M., Ay P., YUCEL E., YUCEL A., et al.
JOURNAL OF EVALUATION IN CLINICAL PRACTICE , cilt.22, sa.5, ss.732-736, 2016 (SCI-Expanded, Scopus) identifier identifier identifier

63. Translation and psychometric evaluation of the Turkish version of the pharmacy students' perceptions of preparedness to provide pharmaceutical care scale

OKUYAN B., SANCAR M., Ay P., Demirkan K., Apikoglu-Rabus S., Izzettin F. V.
PHARMAZIE , cilt.71, sa.10, ss.613-616, 2016 (SCI-Expanded, Scopus) identifier identifier identifier

64. Determination of CYP2C19 Polymorphism, Side Effects, and Medication Adherence in Patients Who have Utilized Selective Serotonin Reuptake Inhibitors

Deniz S., SANCAR M., OKUYAN B., ATA P., Ozakpinar O. B., TALAS A., et al.
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY , cilt.26, sa.2, ss.152-160, 2016 (SCI-Expanded, Scopus, TRDizin) Creative Commons License identifier identifier

65. Determination of pharmaceutical care needs in patients with colon cancer at an ambulatory setting

TEZCAN S., Izzettin F. V., SANCAR M., YUMUK P. F., TURHAL S.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.38, sa.2, ss.557, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

66. Determination of potentially drug-drug interaction in oncology patients

Abunahlah N., SANCAR M., DANE F., Ozyavuz M. K., Izzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.38, sa.2, ss.504, 2016 (SCI-Expanded, Scopus) identifier

67. Observation of dominant occurrence of radiotherapy related acute side effects and management

Al-Taie D. H., KOSEOGLU A., Izzettin F. V., TEZCAN S., Alqozbakr T., AKSU A.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.38, sa.2, ss.572-573, 2016 (SCI-Expanded, Scopus) identifier

68. Assessment of attitude and knowledge in patients utilized disposable insulin pens at community pharmacy setting

OKUYAN B., Semerci Z., Odabasi G., Izzettin F. V., SANCAR M.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.38, sa.2, ss.512, 2016 (SCI-Expanded, Scopus) identifier

69. Implementation of medication reconciliation and medication review services conducted by pharmacist in hospitalized COPD patients

Mamedova S., SANCAR M., Izzettin F. V., DEMIRTUNC R., OKUYAN B.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.38, sa.2, ss.547, 2016 (SCI-Expanded, Scopus) identifier

70. Pharmaceutical Care Impact on Certain Biochemical Levels in Diabetic Cancer Patients

Al-Taie A. H., Izzettin F. V., SANCAR M., KAPTANAGASI A. O.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.38, sa.2, ss.526, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

71. Determination of potential drug-drug interactions by using various software programs at community pharmacy setting

SANCAR M., Kasik A., Batuhan S., Babi B., Izzettin F. V., OKUYAN B.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.38, sa.2, ss.482-483, 2016 (SCI-Expanded, Scopus) identifier

72. Evaluation of potentially inappropriate medication use and drug burden index in elderly patients with cancer

Paksoy C., OKUYAN B., USTAALIOGLU B. B. O., DEMIRTUNC R., Izzettin F. V., SANCAR M.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.38, sa.2, ss.551-552, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

73. Observation of Radiotherapy Related Acute Side Effects Occurrence and Managemenet in Cancer Patients

ALTAİE A., KOSEOGLU A., İZZETTİN F. V., TEZCAN S., ALQOZBAKR T., AKSU A.
International Journal of Pharmacy , cilt.6, ss.11-19, 2016 (Hakemli Dergi) Sürdürülebilir Kalkınma

74. Predictors and differences in patients' self-reporting types to adverse symptomatic events

Anmar A., HADEER A. A., ZEKIYE K. Y., NURGOL K., KERIM C. Y., Izzettin Fikrat V.
European Journal of Clinical Pharmacy , cilt.18, sa.2, ss.130-135, 2016 (Scopus) identifier

75. The effect of topical ethanol extract of Cotinus coggygria Scop. on cutaneous wound healing in rats

AKSOY H., SANCAR M., ŞEN A., OKUYAN B., BİTİŞ L., Uras F., et al.
NATURAL PRODUCT RESEARCH , cilt.30, sa.4, ss.452-455, 2016 (SCI-Expanded, Scopus) identifier identifier identifier

76. Turkish Validation of Patient Satisfaction Towards Patient Oriented Pharmacy Services Questionnaire in Patients with Chronic Disease

OKUYAN B., Hucum H., SANCAR M., Ay P., Izzettin F. V.
CLINICAL AND EXPERIMENTAL HEALTH SCIENCES , cilt.6, sa.4, ss.150-154, 2016 (ESCI, TRDizin) identifier

77. The effect of pharmacist-led education on inhaler use skills in hospitalised patients with chronic obstructive pulmonary disease

SANCAR M., Sirinoglu Y., OKUYAN B., KARAGOZ T., Izzettin F. V.
EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE , cilt.22, sa.6, ss.366-368, 2015 (SCI-Expanded, Scopus) identifier identifier

78. Assessment of the Attitude of Community Pharmacists and Pharmacy Technicians towards Diarrhea: A Simulated Patient Study in Turkey

SANCAR M., Tezcan E., OKUYAN B., Izzettin F. V.
TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH , cilt.14, sa.8, ss.1509-1515, 2015 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

79. The potential role of clinical pharmacists in elderly patients during hospital admission

Selcuk A., SANCAR M., OKUYAN B., DEMIRTUNC R., Izzettin F. V.
PHARMAZIE , cilt.70, sa.8, ss.559-562, 2015 (SCI-Expanded, Scopus) identifier identifier identifier

80. The role of pharmacist in detecting angiotensin converting enzyme inhibitors induced dry cough at community pharmacy setting

Atalay G. C., SANCAR M., OKUYAN B., ATALAY S., Izzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.37, sa.1, ss.207, 2015 (SCI-Expanded, Scopus) identifier

81. Evaluation of Predictive Factors in Patients' Self Reporting Types to Adverse Symptomatic Events

Al-Taie A. H., ABDULRAZZAQ H. A., YILMAZ Z. K., Izzettin F. V., Koramaz N., YILMAZ K. C.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.37, sa.1, ss.180-181, 2015 (SCI-Expanded, Scopus) identifier

82. Evaluation of drug burden index and medication utilization in geriatric patients at community pharmacy

SANCAR M., Girgin I., Selcuk A., Yang S., Izzettin F. V., OKUYAN B.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.37, sa.1, ss.206-207, 2015 (SCI-Expanded, Scopus) identifier

83. Differences in patients' self reporting types to adverse symptomatic events

AL-TAIE A. H., ABDULRAZZAQ H. A., Yilmaz Z. K., Izzettin F. V., KORAMAZ N., YILMAZ K. C.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.37, sa.1, ss.191-192, 2015 (SCI-Expanded, Scopus) identifier

84. Determination of CYP2C19 polymorphisms, adverse drug reaction, and medication adherence in patients utilized selective serotonin reuptake inhibitors

Deniz S., SANCAR M., OKUYAN B., ATA P., Bingol-Ozakpinar O., TALAS A., et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.37, sa.1, ss.231-232, 2015 (SCI-Expanded, Scopus) identifier

85. Assessment of patients' knowledge and attitude towards methotrexate utilization

Dumlu H. I., OKUYAN B., SANCAR M., Izzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.37, sa.1, ss.256, 2015 (SCI-Expanded, Scopus) identifier

86. High performance liquid chromatographic determination of free cisplatin in different cancer types

TEZCAN S., Özdemir F., Turhal S., Izzettin F. V.
Der Pharma Chemica , cilt.5, sa.5, ss.169-174, 2013 (Scopus) Sürdürülebilir Kalkınma identifier

87. The determination of knowledge and attitude of women toward oral contraceptive pills

OKUYAN B., YILMAZ M. A., DENİZ S., ÖZDEMİR A. Ş., SANCAR M., Izzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.35, sa.6, ss.1331-1332, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

88. Assessment of Knowledge, Attitude and Quality of Life in Patients Utilized Topical Corticosteroid

OKUYAN B., Gunduz B., DENİZ S., Sahiner S., SANCAR M., Izzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.35, sa.6, ss.1329-1330, 2013 (SCI-Expanded, Scopus) identifier

89. The Determination of Knowledge and Attitude toward Contraception of Women Utilized Isotretinoin: preliminary study

OKUYAN B., ÖZDEMİR A. Ş., DENİZ S., YILMAZ M. A., Izzettin F. V., SANCAR M.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.35, sa.6, ss.1330-1331, 2013 (SCI-Expanded, Scopus) identifier

90. Attitude and knowledge of hospitalized patients with type 2 diabetes mellitus towards disposable insulin pens utilization

OKUYAN B., Saglam B., EMRE E., Karatas-Kocberber E., Hucum H., DEMIRTUNC R., et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.35, sa.6, ss.1330, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

91. Evaluation of medication utilization skill in geriatric patents: a community pharmacy setting

OKUYAN B., Aslan I. H., Sap S., SANCAR M., Duzgun U. Z., Girgin I., et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.35, sa.5, ss.902, 2013 (SCI-Expanded, Scopus) identifier

92. The implementation of pharmacist driven medication reconciliation program at the admission to hospital

SANCAR M., Er E., TURAN B., Ozker P., Izzettin F. V., OKUYAN B.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.35, sa.5, ss.947-948, 2013 (SCI-Expanded, Scopus) identifier

93. The adverse drug reaction reporting center: a community pharmacy

OKUYAN B., Sahin D., SANCAR M., ŞAHİN C., Atalay M. V., Izzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.35, sa.5, ss.898-899, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

94. The self-care activities of diabetic patients at community pharmacy setting: introduction to pharmaceutical care

OKUYAN B., Ocal Y., SANCAR M., DENİZ S., DAYAN A., DEMIRTUNC R., et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.35, sa.5, ss.896, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

95. Attitude and use of herbal remedies among pregnant women

Konyali T., SANCAR M., Sarica P., TEZCAN S., Yesilyurt M., Izzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.35, sa.5, ss.963, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

96. The evaluation of pharmacy students' perception toward patient oriented pharmacy services

SANCAR M., Beskardesler N., OKUYAN B., Izzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.35, sa.5, ss.903, 2013 (SCI-Expanded, Scopus) identifier

97. Opinion and knowledge towards pharmaceutical care of the pharmacists participated in clinical pharmacy and pharmaceutical care continuing education program Klinik eczaci{dotless}li{dotless}k ve farmasötik baki{dotless}m meslek i̇çi programi{dotless}na kati{dotless}lan eczaci{dotless}lari{dotless}n farmasötik baki{dotless}m hakki{dotless}ndaki bilgi düzeyleri ve görüşleri

SANCAR M., OKUYAN B., Apikoglu-Rabus S., Izzettin F. V.
Turkish Journal of Pharmaceutical Sciences , cilt.10, sa.2, ss.245-253, 2013 (SCI-Expanded, Scopus, TRDizin) identifier

98. Assessment of levofloxacin effect on human neutrophil functions in vitro Levofloksasin'in insan Nötrofil fonksiyonlari üzerine etkisinin in vitro deǧerlendirilmesi

Comerter H., KADİR T., OKUYAN B., SANCAR M., Izzettin F. V.
Turkish Journal of Pharmaceutical Sciences , cilt.10, sa.1, ss.19-24, 2013 (SCI-Expanded, Scopus, TRDizin) identifier

99. Erratum to and corrections on the article entitled "Assessment of medication knowledge and adherence among patients under oral chronic medication treatment in community pharmacy settings"

OKUYAN B., SANCAR M., Izzettin F. V., MORISKY D. E.
Pharmacoepidemiology and Drug Safety , cilt.22, sa.2, ss.218-220, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

100. Assessment of medication knowledge and adherence among patients under oral chronic medication treatment in community pharmacy settings

OKUYAN B., SANCAR M., Izzettin F. V.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY , cilt.22, sa.2, ss.209-214, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

101. Turkish pharmacists' counseling practices and attitudes regarding emergency contraceptive pills

Apikoglu-Rabus S., Clark P. M., Izzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.34, sa.4, ss.579-586, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

102. Comparison of the protective effects of various antiulcer agents alone or in combination on indomethacin-induced gastric ulcers in rats

Izzettin F. V., SANCAR M., OKUYAN B., Apikoglu-Rabus S., Cevikbas U.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY , cilt.64, sa.4, ss.339-343, 2012 (SCI-Expanded, Scopus) identifier identifier identifier

103. Evaluation of quality of life of patients' treated with cisplatin based chemotherapy

Tezcan S., Izzettin F. V., TURHAL S.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.34, sa.1, ss.206-207, 2012 (SCI-Expanded, Scopus) identifier

104. To identify the pharmaceutical care requirements of diabetic patients

Demircioglu C., SANCAR M., Izzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.34, sa.1, ss.207, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

105. Assessment of pharmacy technicians' attitudes and responsibilities toward patient oriented pharmacy practices at community pharmacy

SANCAR M., OKUYAN B., Tamyuksel E., Izzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.34, sa.1, ss.204, 2012 (SCI-Expanded, Scopus) identifier

106. Evaluation of preoperative antibiotic prophylaxis use in a teaching and research hospital in İstanbul İstanbul'daki bir eǧitim ve araşti{dotless}rma hastanesinde preoperatif antibiyotik profilaksisi uygulamasi{dotless}ni{dotless}n deǧerlendirilmesi

Aydin H., SANCAR M., Izzettin F. V.
Marmara Pharmaceutical Journal , cilt.15, sa.2, ss.75-79, 2011 (SCI-Expanded, Scopus) Creative Commons License identifier

107. Determination of geriatric patients' drug profile and identify their pharmaceutical care requirements by determining potential risk factors

SANCAR M., Mutlu B. Y., OKUYAN B., Izzettin F. V.
EUROPEAN GERIATRIC MEDICINE , cilt.2, sa.5, ss.280-283, 2011 (SCI-Expanded, Scopus) identifier identifier

108. Determination of Knowledge and Attitude of Pregnant Women about Drug Usage in Pregnancy

Konyali T., SANCAR M., Sarica P., Izzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.33, sa.2, ss.411, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

109. Effect of addition of montelukast to the asthma maintenance treatment on the clinical and humanistic outcomes

YILDIRIM E., Apikoglu-Rabus S., YILDIZ P., SANCAR M., ANIL B., Izzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.33, sa.2, ss.449, 2011 (SCI-Expanded, Scopus) identifier

110. How much do the faculty courses contribute to daily pharmacy practice?

APIKOGLU-RABUS S., SANCAR M., Izzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.33, sa.2, ss.298, 2011 (SCI-Expanded, Scopus) identifier

111. Determination of knowledge and pharmaceutical care issues in senile osteoporotic women

Yorukoglu E., SAHIN Z., SANCAR M., OKUYAN B., Izzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.33, sa.2, ss.328-329, 2011 (SCI-Expanded, Scopus) identifier

112. Identification potential drug- drug interaction in elderly patients receiving polypharmacy prescription

SANCAR M., Doganyildiz P., OKUYAN B., Izzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.33, sa.2, ss.407, 2011 (SCI-Expanded, Scopus) identifier

113. Outcomes of diabetes risk-testing performed at community pharmacy setting

APIKOGLU-RABUS S., Ture Z., SANCAR M., OKUYAN B., Soydeger-Carli B., YILMAZ Z., et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.33, sa.2, ss.401-402, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

114. The Effect of Pharmacist-Led Education on Skills of Patients with Chronic Obstructive Pulmonary Disease in Using Inhaler Device

SIRINOGLU Y., SANCAR M., Karagoez T., Izzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.33, sa.2, ss.316, 2011 (SCI-Expanded, Scopus) identifier

115. Cardiovascular disease risk assessment among patients with hyperlipidemia at a community pharmacy setting

SANCAR M., Akyildiz E., OKUYAN B., RABUŞ Ş., Carli B. S., YILMAZ Z., et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.33, sa.2, ss.429-430, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

116. Determination of knowledge and attitude of self-care among patients with hypertension

OKUYAN B., GULES M. E., SANCAR M., RABUŞ Ş., Carli B. S., Izzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.33, sa.2, ss.424, 2011 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

117. Characteristics of the drug-disease information service demanded from the community pharmacist

APIKOGLU-RABUS S., Pakalpakcil O., OKUYAN B., SANCAR M., Soydeger-Carli B., Izzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.33, sa.2, ss.335-336, 2011 (SCI-Expanded, Scopus) identifier

118. Effect of pharmacist intervention on patient compliance in treatment of upper respiratory tract infections in children

Sarica P., Izzettin F. V., SANCAR M.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.33, sa.2, ss.409, 2011 (SCI-Expanded, Scopus) identifier

119. İstanbul daki bir eğitim ve araştırma hastanesinde preoperatif antibiyotik profilaksisi uygulamasının değerlendirilmesi

AYDIN H., SANCAR M., İZZETTİN F. V.
Marmara Üniversitesi Eczacılık Dergisi , cilt.0, ss.75-79, 2011 (Hakemli Dergi)

120. Turkish pharmacy technicians' counseling practices and attitudes regarding emergency contraceptive pills

Apikoglu-Rabus S., SANCAR M., OKUYAN B., Izzettin F. V.
AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY , cilt.5, sa.1, ss.60-66, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

121. A patient-drug profile study in acute myocardial infarction

Erzen T., SANCAR M., Okuyan B., Izzettin F. V.
PHARMACY WORLD & SCIENCE , cilt.32, sa.2, ss.305, 2010 (SCI-Expanded) identifier

122. THE EFFECT OF STATIN TREATMENT ON INFLAMMATION AND QUALITY OF LIFE IN PATIENTS WITH HEART FAILURE

YEŞİLDAĞ O., Karatas P., Ozben B., Izzettin F. V.
INTERNATIONAL JOURNAL OF CARDIOLOGY , cilt.140, 2010 (SCI-Expanded, Scopus) identifier

123. Medication use evaluation during acute exacerbation and stable periods in patients with chronic obstructive pulmonary disease

Soydeger-Carli B., SANCAR M., OKUYAN B., Carli O., KARAGOZ T., Izzettin F. V.
PHARMACY WORLD & SCIENCE , cilt.32, sa.2, ss.306, 2010 (SCI-Expanded) identifier

124. Effect of topical insulin on cutaneous wound healing in rats with or without acute diabetes

Apikoglu-Rabus S., Izzettin F. V., Turan P., ERCAN F.
CLINICAL AND EXPERIMENTAL DERMATOLOGY , cilt.35, sa.2, ss.180-185, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

125. Improvement of diabetes indices of care by a short pharmaceutical care program

Turnacilar M., SANCAR M., Apikoglu-Rabus S., HURSITOGLU M., Izzettin F. V.
PHARMACY WORLD & SCIENCE , cilt.31, sa.6, ss.689-695, 2009 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

126. Comparative effectiveness of Glycyrrhiza glabra vs. omeprazole and misoprostol for the treatment of aspirin-induced gastric ulcers

SANCAR M., Hantash T., OKUYAN B., Apikoglu-Rabus S., CIRAKLI Z., Gulluoglu M. G., et al.
AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY , cilt.3, sa.12, ss.615-620, 2009 (SCI-Expanded, Scopus) identifier identifier

127. Quality of life in patients with tuberculosis

Izzettin F. V., Eminzade S., Apikoglu-Rabus S., KARAGOZ T.
PHARMACY WORLD & SCIENCE , cilt.31, sa.1, ss.61-62, 2009 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

128. The quality of life and pharmaceutical care requirements of the hypertension patients in a community pharmacy

Izzettin F. V., Nakiboglu V. S., SANCAR M.
PHARMACY WORLD & SCIENCE , cilt.31, sa.1, ss.98, 2009 (SCI-Expanded) identifier

129. Community pharmacists' opinion on pharmaceutical care practice in Turkey

SANCAR M., OKUYAN B., Rabus S. A., Izzettin F. V.
PHARMACY WORLD & SCIENCE , cilt.31, sa.1, ss.97, 2009 (SCI-Expanded, Scopus) identifier identifier identifier

130. The economic impact of a generic substitution based reimbursement system for type-2 diabetes

Apikoglu-Rabus S., Yurtseven S. P., Guler O., Soydeger B., RABUS M. B., DEMİRCİOĞLU S., et al.
PHARMACY WORLD & SCIENCE , cilt.31, sa.1, ss.106-107, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

131. Effects of antituberculous drugs and their combinations on human polymorphonuclear leukocyte functions in vitro

Ertaş Ö., Çevikbaş A., SOYOĞUL GÜRER Ü., OKUYAN B., RAYAMAN P., RAYAMAN E., et al.
Turkish Journal of Pharmaceutical Sciences , cilt.5, sa.3, ss.117-127, 2008 (SCI-Expanded, Scopus, TRDizin) identifier

132. Five-year follow-up of drug utilization for secondary prevention in coronary artery disease

Rabus S. A., Izzettin F. V., SANCAR M., KARAKAYA O., KARGIN R., YAKUT C.
PHARMACY WORLD & SCIENCE , cilt.30, sa.6, ss.753-758, 2008 (SCI-Expanded, Scopus) identifier identifier identifier

133. Determination of geriatric patients' drug profile and identify their pharmaceutical care requirement

Yalcin B., SANCAR M., Izzettin F. V.
PHARMACY WORLD & SCIENCE , cilt.30, sa.5, ss.705-706, 2008 (SCI-Expanded) identifier

134. The role of the clinical pharmacist on oncology service: pain management

Sevgen D., Izzettin F. V., Turhal S.
PHARMACY WORLD & SCIENCE , cilt.30, sa.5, ss.676, 2008 (SCI-Expanded) identifier

135. An evaluation of systemic and topical treatments of otitis media: a hospital study in Turkey

Eken M., OKUYAN B., SANCAR M., EKEN M., Izzettin F. V.
PHARMACY WORLD & SCIENCE , cilt.30, sa.5, ss.731-732, 2008 (SCI-Expanded) identifier

136. The role of community pharmacist on oral and dental health: prevention of diseases and toothache management

Tunc S., SANCAR M., Sarica P., Izzettin F. V.
PHARMACY WORLD & SCIENCE , cilt.30, sa.5, ss.716, 2008 (SCI-Expanded) identifier

137. Fourth-grade pharmacy students prefer kinesthetic learning

Rabus S. A., Izzettin F. V.
PHARMACY WORLD & SCIENCE , cilt.30, sa.5, ss.687, 2008 (SCI-Expanded) identifier

138. The incidence of dry cough in angiotensin-converting enzyme inhibitor users

Ozyalcin M., SANCAR M., Izzettin F. V.
PHARMACY WORLD & SCIENCE , cilt.30, sa.5, ss.715-716, 2008 (SCI-Expanded) identifier

139. Silymarin protects liver against toxic effects of anti-tuberculosis drugs in experimental animals

Eminzade S., Uraz F., Izzettin F. V.
NUTRITION & METABOLISM , cilt.5, 2008 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

140. Massive creatine kinase increase during quetiapine and mirtazapine treatment

Rabus S. A., Izzettin F. V., Rabus M. B., Bilici M.
PHARMACY WORLD & SCIENCE , cilt.29, sa.5, ss.460-461, 2007 (SCI-Expanded) identifier

141. Cardiovascular drug prescription in type 2 diabetes

Izzettin F. V., RABUS S. A., SANCAR M., GEBELOGLU N., HURSITOGLU M.
PHARMACY WORLD & SCIENCE , cilt.29, sa.5, ss.513-514, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

142. Effect of pharmacist-led patient education on adherence to tuberculosis treatment

CLARK P. M., KARAGOZ T., APIKOGLU-RABUS S., Izzettin F. V.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY , cilt.64, sa.5, ss.497-506, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

143. Pharmacoeconomic comparison of Helicobacter pylori eradication regimens

SANCAR M., Izzettin F. V., APIKOGLU-RABUS S., BESISIK F., TOZUN N., DULGER G.
PHARMACY WORLD & SCIENCE , cilt.28, sa.4, ss.207-214, 2006 (SCI-Expanded, Scopus) identifier identifier identifier

144. Severe creatine kinase increase during quetiapine and mirtazapine treatment

Rabus S. A., Izzettin F. V., Rabus M., Bilici M.
Psychopharmacology , cilt.185, sa.2, ss.263-264, 2006 (SCI-Expanded, Scopus) identifier identifier identifier

145. Effect of antituberculous drugs on human polymorphonuclear leukocyte functions in vitro

OKUYAN B., Izzettin F. V., SANCAR M., ERTAS O., CEVIKBAS A., GURER U.
INTERNATIONAL IMMUNOPHARMACOLOGY , cilt.5, ss.1337-1342, 2005 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

146. Therapeutic monitoring of isoniazid, pyrazinamide and rifampicin in tuberculosis patients using LC

UNSALAN S., SANCAR M., BEKCE B., CLARK P., KARAGOZ T., Izzettin F. V., et al.
CHROMATOGRAPHIA , cilt.61, ss.595-598, 2005 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

147. Cost-effectiveness of thrombolytics: a simplified model

RABUS S., Izzettin F. V., SANCAR M., RABUS M., KIRMA C., YAKUT C.
PHARMACY WORLD & SCIENCE , cilt.27, sa.3, ss.243-248, 2005 (SCI-Expanded, Scopus) identifier identifier identifier

148. Improvement in pharmacists' knowledge through professional inservice education programs

Demirkan K., ÇELİKER A., Yilmaz D., SANCAR M., Apikoǧlu Rabuş Ş., Izzettin F. V., et al.
Fabad Journal of Pharmaceutical Sciences , cilt.29, sa.3, ss.117-120, 2004 (Scopus) identifier

149. Nephrotoxicity of piroxicam in rats

Ahmed E. Y., Izzettin F. V., Ayca B., SANCAR M., STOHS S. J.
Research Communications in Pharmacology and Toxicology , cilt.8, ss.27-33, 2003 (Scopus) identifier identifier

150. Nephrotoxicity of gentamicin and ceftriaxone combination in male rats

Ayca B., Izzettin F. V., Yurptsever E., Kilicarslan I., Alsharif N. Z.
Research Communications in Pharmacology and Toxicology , cilt.7, ss.65-75, 2002 (Scopus) identifier

151. Implementation of clinical pharmacy in Turkey

Izzettin F. V.
Pharmacia , cilt.45, sa.1, ss.34-39, 1998 (Scopus) identifier

152. Effects of ketorolac on renal and hematological parameters

SANCAR M., Izzettin F. V., GUMUS A., UGAR M., URAS A., CEVIKBSA U., et al.
Research Communications in Pharmacology and Toxicology , cilt.3, ss.114-122, 1998 (Scopus) identifier

153. NEPHROTOXICITY OF GENTAMICIN AND COTRIMOXAZOLE COMBINATION IN RATS

IZZETTIN F., AYCA B., URAS F., UYSAL V., CEVIKBAS U., YARDIMCI T., et al.
GENERAL PHARMACOLOGY , cilt.25, sa.6, ss.1185-1189, 1994 (SCI-Expanded, Scopus) identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 86

1. Çocuklarda Üst Solunum Yolu Enfeksiyonlarında Ebeveyn Bilgi, Tutum ve Uygulamalarının Değerlendirilmesi: Kesitsel Bir Çalışma

Sunucu E., Mercümek B., Bektay M. Y., İzzettin F. V.
9. Ulusal Hastane ve Kurum Eczacıları Kongresi, İskele, Kıbrıs (Kktc), 13 - 17 Aralık 2023, ss.1-2, (Özet Bildiri)

2. Assessing the Management of Hospitalized Cystic Fibrosis Patients: Recommendations for Optimizing Pharmacists' Roles

Mercümek B., Bektay M. Y., Uzuner S., İzzettin F. V.
BIO Türkiye International Biogtechnology Congress: BioTechnology Ecosystem For A Sustainable Life, İstanbul, Türkiye, 28 - 30 Eylül 2023, ss.102-103, (Özet Bildiri)

3. A Study of The Association Between Medication Adherence and Self-Care Activities In Patients With Type 2 Diabetes Mellitus.

Demirhan Ş., Bektay M. Y., Şekerci A., Güler E. M., İzzettin F. V.
4. International Hasankeyf Scientific Research And Innovation Congress , Batman, Türkiye, 30 Nisan 2023, ss.388, (Özet Bildiri) Sürdürülebilir Kalkınma

4. Evaluation of analgesic use behaviors of individuals for pain management: an observational study

Koroglu F. N., Mercumek B., Bektay M. Y., Izzettin F. V.
50th ESCP Symposium on Clinical Pharmacy, Polypharmacy and ageing - highly individualized, interprofessional, person-centered care., Praha, Çek Cumhuriyeti, 19 - 21 Ekim 2022, cilt.44, ss.1503, (Özet Bildiri) identifier

5. Identification of potentially inappropriate medications in elderly according to the FORTA and EU (7)-PIM lists: an observational study

Ozmen O., Bektay M. Y., Karatoprak C., Izzettin F. V.
50th ESCP Symposium on Clinical Pharmacy, Polypharmacy and ageing - highly individualized, interprofessional, person-centered care. , Praha, Çek Cumhuriyeti, 19 - 21 Ekim 2022, cilt.44, ss.1528-1529, (Özet Bildiri) identifier

6. Investigation of drug-related problems in hospitalized patients with respiratory diseases: a randomized controlled trial

Bektay M. Y., Sancar M., Okyaltirik F., Durdu B., Izzettin F. V.
50th ESCP Symposium on Clinical Pharmacy, Polypharmacy and ageing - highly individualized, interprofessional, person-centered care, Praha, Çek Cumhuriyeti, 19 - 21 Ekim 2022, cilt.44, ss.1484, (Özet Bildiri) identifier

7. Identification and evaluation of drug-related problems in the cardiology ward: an interventional study

Sosyal D., Bektay M. Y., Acikgoz N., Izzettin F. V.
50th ESCP Symposium on Clinical Pharmacy, Polypharmacy and ageing - highly individualized, interprofessional, person-centered care., Praha, Çek Cumhuriyeti, 19 - 21 Ekim 2022, cilt.44, ss.1520, (Özet Bildiri) identifier

8. FARMASÖTİK BAKIM HİZMETİNİN DİYABET PROGNOZUNA ETKİLERİNİN DEĞERLENDİRİLMESİ

Kutluay N. B., Bektay M. Y., Sümbül Şekerci B., Şekerci A., İzzettin F. V.
Istanbul 3rd Internatıonal Modern Scıentıfıc Research Congress , İstanbul, Türkiye, 6 - 08 Mayıs 2022, ss.56-57, (Özet Bildiri) Sürdürülebilir Kalkınma

9. ECZACILARIN ASTIM FARMASÖTİK BAKIMINDA BİLGİ SEVİYESİ TUTUM VE DAVRANIŞLARININ ARAŞTIRILMASI

Çakmak D., Bektay M. Y., Al-Ezzi S. A. A., İzzettin F. V.
İstanbul 3rd International Modern Scientific Research Congress, İstanbul, Türkiye, 6 - 08 Mayıs 2022, ss.169-171, (Özet Bildiri)

10. Determination of the Knowledge Level Of Pharmacists About Alzheimer Disease

Zeybek E., Bektay M. Y., İzzettin F. V.
3rd International Gazi Pharma Symposium Series, Ankara, Türkiye, 8 - 10 Eylül 2021, ss.90, (Özet Bildiri)

11. Investigation of the Anxiety and Knowledge Levels of Individuals: the Role of Pharmacist

Tütüncü B., Sosyal D., Bektay M. Y., İzzettin F. V.
3rd International Gazi Pharma Symposium Series, Ankara, Türkiye, 8 - 10 Eylül 2021, ss.89, (Özet Bildiri)

12. Are Students Using Pharmacological Cognitive Enhancement More Successful?

Sümbül Şekerci B., Bektay M. Y., Bildik Ö., İzzettin F. V.
49th Meeting of the European Brain and Behaviour Society, Lausanne, İsviçre, 4 - 07 Eylül 2021, ss.259, (Özet Bildiri) Sürdürülebilir Kalkınma

13. Determination of Pharmaceutical Care Needs of COVID-19 Patients in the 1st Wave of Pandemic

Gökçe N., Bektay M. Y., İzzettin F. V.
3rd International Gazi Pharma Symposium Series, Ankara, Türkiye, 8 - 10 Eylül 2021, ss.87, (Özet Bildiri) Sürdürülebilir Kalkınma

14. Serum Lityum Düzeyi Yüksek Olan Hastada Olası İlaçla İlgili Problemler: Bir Olgu Raporu

Özmen Ö., Sosyal D., Bektay M. Y., Gürsoy A. E., İzzettin F. V.
OLGULARLA KLİNİK ECZACILIK ÇALIŞTAYI, İstanbul, Türkiye, 17 Haziran 2021, ss.3, (Özet Bildiri)

15. Böbrek Yetmezliğinde Alfa-1 Adrenerjik Reseptör Blokör Kullanımı: Bir Olgu Raporu

Bekler T., Bektay M. Y., Karatoprak C., İzzettin F. V.
OLGULARLA KLİNİK ECZACILIK ÇALIŞTAYI, İstanbul, Türkiye, 17 Haziran 2021, ss.13, (Özet Bildiri)

16. Levodopa Kullanımına Bağlı Olası İlaç Kaynaklı Pansitopeni: Bir Olgu Raporu

Özkanlı Ö. F., Bektay M. Y., Karatoprak C., İzzettin F. V.
OLGULARLA KLİNİK ECZACILIK ÇALIŞTAYI, İstanbul, Türkiye, 17 Haziran 2021, ss.7, (Özet Bildiri)

17. Comparision of different decision support software programs in perspective of potential drug-drug interactions in oncology clinic

BEKTAY M. Y., Şeker Z., eke h. k., TÜRK H. M., İZZETTİN F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, Lübiyana, Slovenya, 23 - 25 Ekim 2020, cilt.42, ss.229, (Özet Bildiri) identifier identifier

18. Evaluation of parents’xx knowledge and attitude about antipyretics

İZZETTİN F. V., SANCAR M.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 23 - 25 Ekim 2019, cilt.42, ss.238, (Özet Bildiri)

19. Evaluation of medication regimen complexity and medication adherence in patients with Benign Prostatic Hyperplasia

İZZETTİN F. V., SANCAR M., OKUYAN B.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 23 - 25 Ekim 2019, cilt.42, ss.249, (Özet Bildiri)

20. Comparison of different decision support software programs in perspective of potential drug-drug interactions in oncology clinic.

Bektay M. Y., Şeker Z., Eke H. K., Türk H. M., İzzettin F. V.
48TH SYMPOSIUM OF EUROPEAN SOCIETY OF CLINICAL PHARMACY (ESCP), Ljubljana, Slovenya, 22 Ekim 2019, cilt.42, ss.229, (Özet Bildiri)

21. Evaluation of the quality of life, attitudes and perceptions in patients with benign prostatic hyperplasia

İZZETTİN F. V., SANCAR M.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 23 - 25 Ekim 2019, cilt.42, ss.235-236

22. Evaluation of Parents’ Knowledge and Attitude about Antipyretics

BAHADIR A., İZZETTİN F. V., ŞAHİN Y., OKUYAN B., SANCAR M.
ESCP 48th International Symposium on Clinical Pharmacy, Ljubljana, Slovenya, 23 - 25 Ekim 2019, (Özet Bildiri)

23. Comparison of Different Decision Support Software Programs in Perspective of Potential Drug-Drug Interactions In Oncology Clinic

Bektay M. Y., Şeker Z., Eke H. K., Türk H. M., İzzettin F. V.
48th ESCP Symposium. The Digital Revolution: Supporting clinical pharmacy through e-health, digital support systems, big data and more., Ljubljana, Slovenya, 23 - 25 Ekim 2019, ss.229, (Özet Bildiri) Sürdürülebilir Kalkınma

24. Türkiye’de klinik eczacılık eğitiminin gelişimi: Marmara modeli”

SANCAR M., RABUŞ Ş., OKUYAN B., İZZETTİN F. V., KÜÇÜKGÜZEL Ş. G.
2. Ulusal Marmara Eczacılık Kongresi, Türkiye, 14 - 16 Kasım 2018, (Özet Bildiri)

25. Marmara Üniversitesi’nde eczacılıkta uzmanlık eğitimi: İlk deneyimler

SANCAR M., RABUŞ Ş., OKUYAN B., İZZETTİN F. V., KÜÇÜKGÜZEL Ş. G.
2. Ulusal Marmara Eczacılık Kongresi, Türkiye, 14 - 16 Kasım 2018, (Özet Bildiri)

26. All you need to know about clinical rounds: from design to assessment.

İZZETTİN F. V., RABUŞ Ş., SANCAR M.
ESCP47th European Symposium on Clinical Pharmacy, 24 - 26 Ekim 2018

27. Evaluatıon of knowledge and attıtudes of patıents and pharmacısts on usıng herbal products.

TEZCAN S., KIZILKAYA M., SANCAR M., İZZETTİN F. V.
47th ESCP Symposium on Clinical Pharmacy ”Personalised Pharmacy Care, Belfast, Birleşik Krallık, 24 - 26 Ekim 2018, (Özet Bildiri)

28. Evaluatıon of knowledge and attıtudes of patıents usıng eye drops / oıntments.

KILIÇASLAN Ö., SANCAR M., TEZCAN S., İZZETTİN F. V.
12th International Symposium on Pharmaceutical Sciences (ISOPS-12)., Ankara, Türkiye, 26 - 29 Haziran 2018, (Özet Bildiri)

29. Onkoloji Eczacılığına Giriş ve Farmasötik Bakımın İlkeleri

İZZETTİN F. V.
Hastane Eczacılığında Kanser Olguları Çalıştayı, Edirne, Türkiye, 10 - 11 Kasım 2017, (Tam Metin Bildiri)

30. Evaluation of Internet-based Drug Information Center Conducted by Clinical Pharmacist

İZZETTİN F. V., YILMAZ Z. K., OKUYAN B., SANCAR M.
International Meeting on Education and Research in Health Sciences (IMER-HS), İstanbul, Türkiye, 3 - 05 Kasım 2017, (Özet Bildiri)

31. Plasma Levels of Growth Arrest-Specific 6 in Colon Cancer Patients

İZZETTİN F. V., TEZCAN S., BİNGÖL ÖZAKPINAR Ö., ATTALLAH W., YUMUK P. F., URAS F.
International Meeting on Education and Research in Health Sciences (IMER-HS), İstanbul, Türkiye, 3 - 05 Kasım 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

32. Evaluation of Internet-based Drug Information Center Conducted by Clinical Pharmacist.

İZZETTİN F. V., YILMAZ Z., OKUYAN B., SANCAR M.
International Meeting on Education and Research in Health Sciences (IMER-HS), İstanbul, Türkiye, 3 - 05 Kasım 2017, (Özet Bildiri)

33. Evaluation of Internet-based Drug Information Center Conducted by Clinical Pharmacist

İZZETTİN F. V., YILMAZ Z. K., OKUYAN B., SANCAR M.
International Meeting on Education and Research in Health Sciences, 3 - 05 Kasım 2017, (Özet Bildiri)

34. plasma levels of growth arrest spesific 6 in colon cancer patients

TEZCAN S., İZZETTİN F. V., BİNGÖL ÖZAKPINAR Ö., ATALAY V., YUMUK P. F., URAS F.
İnternational meeting on eduacation and research in health sciences, 03 Kasım 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

35. Evaluation of the different patient education methods given by the clinical pharmacist

YILMAZ Z. K., SANCAR M., OKUYAN B., YEŞİLDAĞ O., İZZETTİN F. V.
46th European Society of Clinical Pharmacy (ESCP) Symposium on Clinical Pharmacy, Heidelberg, Almanya, 9 - 11 Ekim 2017, (Özet Bildiri)

36. The role of clinical pharmacist in evaluation of cardiometabolic risk and drug related problems in patients with bipolar disorder

YANG S., SANCAR M., OKUYAN B., BİNGÖL ÖZAKPINAR Ö., NEBİOĞLU M., ÇALIŞKAN M., et al.
46th European Society of Clinical Pharmacy (ESCP) Symposium on Clinical Pharmacy, Heidelberg, Almanya, 9 - 11 Ekim 2017, (Özet Bildiri)

37. Medication adherence and medication regimen complexity of patients with polypharmacy setting

LEBLEBİCİ A., TORUN B., ÖZKAN Ö., ÖZDEMİR B., BELENTEPE A., İNCE İ., et al.
46th European Society of Clinical Pharmacy (ESCP) Symposium on Clinical Pharmacy, Heidelberg, Almanya, 9 - 11 Ekim 2017, (Özet Bildiri)

38. Medication errors facing the hospitalized cardiovascular disease

SİZGEN F., RABUŞ Ş., İZZETTİN F. V.
46th European Society of Clinical Pharmacy (ESCP) Symposium on Clinical Pharmacy, Heidelberg, Almanya, 9 - 11 Ekim 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

39. Evaluation of Pharmacist’s role related to corticosteroid usage: Corticophobia

İZZETTİN F. V., TEZCAN S., Çakıcı G., ŞAHİN Y., SANCAR M.
46th European Society of Clinical Pharmacy (ESCP) Symposium on Clinical Pharmacy, Heidelberg, Almanya, 9 - 11 Ekim 2017, (Özet Bildiri)

40. Evaluation of the different patient education methods given by the clinical pharmacist.

YILMAZ Z., SANCAR M., OKUYAN B., YEŞİLDAĞ O., İZZETTİN F. V.
46th European Society of Clinical Pharmacy (ESCP) Symposium on Clinical Pharmacy, Heidelberg, Almanya, 9 - 11 Ekim 2017, ss.89, (Özet Bildiri)

41. The evaluation of parents attitude towards antibiotic use in children in the age of primary school

AK D., İZZETTİN F. V., OKUYAN B., SANCAR M.
46th European Society of Clinical Pharmacy (ESCP) Symposium on Clinical Pharmacy, Heidelberg, Almanya, 9 - 11 Ekim 2017, (Özet Bildiri)

42. Importance of Medication Dose Adjustment in Hospitalized Patients with Impaired Renal Function at Internal Medicine Ward: The Possible Impact of Clinical Pharmacist

Altan A., Ozkan O., DEMİRTUNÇ R., OKUYAN B., İZZETTİN F. V., SANCAR M.
46th ESCP Symposium on Clinical Pharmacy, Heidelberg, Almanya, 9 - 11 Ekim 2017, (Özet Bildiri)

43. Importance of medication dose adjustment in hospitalized patients with impaired renal function at internal medicine ward:the possible impact of clinical pharmacist.

ALTAN A., ÖZKAN Ö., DEMİRTUNÇ R., OKUYAN B., İZZETTİN F. V., SANCAR M.
46th European Society of Clinical Pharmacy (ESCP) Symposium on Clinical Pharmacy, Heidelberg, Almanya, 9 - 11 Ekim 2017, (Özet Bildiri)

44. Inter-professional training:the importance of clinical rounds in clinical pharmacy education

SANCAR M., İZZETTİN F. V., OKUYAN B.
46th European Society of Clinical Pharmacy (ESCP) Symposium on Clinical Pharmacy, Heidelberg, Almanya, 9 - 11 Ekim 2017, (Özet Bildiri)

45. Inter-professional Training: The Importance of Clinical Rounds in Clinical Pharmacy

SANCAR M., İZZETTİN F. V., OKUYAN B.
46th ESCP Symposium on Clinical Pharmacy, 9 - 11 Ekim 2017, (Özet Bildiri)

46. Medication adherence and medication regimen complexity of patients with polypharmacy at community pharmacy setting

LEBLEBİCİ A., TORUN B., ÖZKAN Ö., ÖZDEMİR B., BELENTEPE A., İNCE İ., et al.
46th ESCP Symposium on Clinical Pharmacy, 9 - 11 Ekim 2017, (Özet Bildiri)

47. Medication errors facing the hospitalized cardiovascular disease patients

Sizgen F., RABUŞ Ş., İZZETTİN F. V.
46th European Society of Clinical Pharmacy (ESCP) Annual Symposium, Heidelberg, Germ, 9 - 11 Ekim 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

48. The Evaluation of Parents Attitude Towards Antibiotic Use in Children In the Age of Primary School

AK D., İZZETTİN F. V., OKUYAN B., SANCAR M.
46th ESCP Symposium on Clinical Pharmacy, 9 - 11 Ekim 2017, (Özet Bildiri)

49. Importance of Medication Dose Adjustment in Hospitalized Patients with Impaired Renal Function at Internal Medicine Ward: The Possible Impact of Clinical Pharmacist

ALTAY A., ÖZKAN Ö., DEMİRTUNÇ R., OKUYAN B., İZZETTİN F. V., SANCAR M.
46th ESCP Symposium on Clinical Pharmacy, October 2017, 9 - 11 Ekim 2017, (Özet Bildiri)

50. Tüberküloz tedavisi alan çocuk hastalarda yüksek basınçlı sıvı kromatografi yöntemi ile terapötik ilaç izlemi

KARAKUŞ S., SANCAR M., DALGIC N., OKUYAN B., ÇAKIR E., MIDYAT L., et al.
17.Kromatografi Kongresi (Kromatografi 2017), Çorum, Türkiye, 20 - 22 Eylül 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

51. Karar sürecine sistematik yaklaşım

İZZETTİN F. V.
Pharmaclass Serbest Eczacılar için Hasta-Odaklı Yaz Okulu, Bodrum, Türkiye, 18 - 21 Mayıs 2017

52. Hasta izlemi ve klinik uygulama becerileri interaktif atölye çalışması,

İZZETTİN F. V., SANCAR M., RABUŞ Ş., OKUYAN B.
Pharmaclass Serbest Eczacılar için Hasta-Odaklı Yaz Okulu, Bodrum, Türkiye, 18 - 21 Mayıs 2017

53. Kortikosteroidlerin klinik Kullanımı

İZZETTİN F. V.
Pharmaclass Serbest Eczacılar için Hasta-Odaklı Yaz Okulu, Bodrum, Türkiye, 18 - 21 Mayıs 2017

54. Klinik Onkoloji Eczacılığı ve Farmasötik Bakım

TEZCAN S., İZZETTİN F. V.
3.İVEK KONGRESİ, İstanbul, Türkiye, 26 - 29 Nisan 2017, (Özet Bildiri)

55. Ebeveynlerin ilköğretim çağındaki çocuklarda antibiyotik kullanımı hakkındaki tutumlarının değerlendirilmesi,

AK D., İZZETTİN F. V., SANCAR M., OKUYAN B.
3. İVEK, 26 - 29 Nisan 2017, (Özet Bildiri)

56. Dahiliye servisine yatan hastalarıkullandıkları ilaçlar arasındaki olası ilaç-ilaç etkileşimleri

ODABAŞI G., OKUYAN B., İZZETTİN F. V., DEMİRTUNÇ R., SANCAR M.
3. Ulusal Klinik Eczacılık Farmasötik Bakım Kongresi, Türkiye, 9 - 12 Şubat 2017, (Özet Bildiri)

57. Kanser ve Onkoloji Eczacılığına Genel Bakış

İZZETTİN F. V.
3. Ulusal Klinik Eczacılık Farmasötik Bakım Kongresi, Türkiye, 9 - 12 Şubat 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

58. Astım Hastalarında Hastalık Algısının ve Tedavi Profillerinin İncelenmesi

BABADAĞLI U., OKUYAN B., SANCAR M., İZZETTİN F. V.
I. Ulusal Marmara Eczacılık Kongresi, İstanbul, Türkiye, 3 - 05 Kasım 2016, (Özet Bildiri)

59. Astım ve Kronik Obstrüktif Akciğer Hastalığı Olanlarda Mevsimsel Grip ve Pnömokok Aşılarının Kullanımı

ÖZYILDIZ N., SANCAR M., OKUYAN B., İZZETTİN F. V.
I. Ulusal Marmara Eczacılık Kongresi, İstanbul, Türkiye, 3 - 05 Kasım 2016, (Özet Bildiri) Sürdürülebilir Kalkınma

60. Diyabetli Hastalarda Gıda Takviyesi Kullanımı

SÜRMELİ Ç., OKUYAN B., SANCAR M., İZZETTİN F. V.
I. Ulusal Marmara Eczacılık Kongresi, İstanbul, Türkiye, 3 - 05 Kasım 2016, (Özet Bildiri) Sürdürülebilir Kalkınma

61. Impact of a pharmaceutical care program on glycemic control medication knowledge and medication adherence levels of type 2 diabetic patients residing at a nursing home

SAĞLAM N., RABUŞ Ş., OKUYAN B., İZZETTİN F. V., YILDIRIM N.
45th European Society of Clinical Pharmacy (ESCP) Annual Symposium, Oslo, Norveç, 5 - 07 Ekim 2016, (Özet Bildiri) Sürdürülebilir Kalkınma

62. Assessment of port catheter complications in cancer patients impact of clinical pharmacist care

KÖSEOĞLU A., ALTAİE A., ALİUSTAOĞLU M., SANCAR M., İZZETTİN F. V.
45th European Society of Clinical Pharmacy (ESCP) Annual Symposium, Oslo, Norveç, 5 - 07 Ekim 2016, (Özet Bildiri) Sürdürülebilir Kalkınma

63. Drug drug interactions identified for cardiac transplant recipients

RABUŞ Ş., RABUŞ M., ÖZKAN Ö., ŞAHİN Y., İZZETTİN F. V.
45th European Society of Clinical Pharmacy (ESCP) Annual Symposium, Oslo, Norveç, 5 - 07 Ekim 2016, (Özet Bildiri)

64. The Evaluation of Elderly Patient's medication Profile at Community Pharmacy Setting

OKUYAN B., ATAKUL N., ÖZKAN Ö., İZZETTİN F. V., SANCAR M.
45th ESCP Symposium on Clinical Pharmacy, Oslo, Norveç, 5 - 07 Ekim 2016, (Özet Bildiri)

65. Investigation of Medication Profile of Patients During Hospital Admission

ODABAŞI G., SANCAR M., OKUYAN B., İZZETTİN F. V., DEMİRTUNÇ R.
45th European Society of Clinical Pharmacy (ESCP) Annual Symposium, Oslo, Norveç, 5 - 07 Ekim 2016, (Özet Bildiri)

66. Impact of Patient Education on Glycemic Control Medication Knowledge Level and Medication Adherence of Patients with Type 2 Diabetes

RABUŞ Ş., ŞERO M., OKUYAN B., İZZETTİN F. V.
45th European Society of Clinical Pharmacy (ESCP) Annual Symposium, Oslo, Norveç, 5 - 07 Ekim 2016, (Özet Bildiri) Sürdürülebilir Kalkınma

67. Type 2 diabetes risk assessment program for children and adolescents at the community pharmacy setting

RABUŞ Ş., KOÇBERBER KARATAŞ E., İZZETTİN F. V.
45th European Society of Clinical Pharmacy (ESCP) Annual Symposium, Oslo, Norveç, 5 - 07 Ekim 2016, (Özet Bildiri) Sürdürülebilir Kalkınma

68. Evaluation of Rational Antibiotic Dispensing in the Community Pharmacy Setting: A Simulated Patient Study

OKUYAN B., SAVAN M. A., İZZETTİN F. V., SANCAR M.
45th ESCP Symposium on Clinical Pharmacy, Oslo, Norveç, 5 - 07 Ekim 2016, (Özet Bildiri)

69. Hasta odaklı eczacı olmak ne demek

İZZETTİN F. V.
PharmaClass II, Türkiye, 26 - 29 Mayıs 2016, (Özet Bildiri)

70. Küçükgüzel Eczacılık Eğitiminde Klinik Uygulamaların Önemi Marmara Üniversitesi Örneği

SANCAR M., RABUŞ Ş., OKUYAN B., TEZCAN S., ÖZKAN Ö., ŞAHİN Y., et al.
I.Ulusal Eczacılık Eğitimi ve Akreditasyon Kongresi, Ankara, Türkiye, 9 - 10 Mayıs 2016, (Özet Bildiri)

71. Eczacılık Öğrencilerinin Farmasötık Bakıma Hazırlık Algısı Ölçeğinin Türkçe Versiyonunun Psikometrik Özelliklerinin Değerlendirilmesi

OKUYAN B., SANCAR M., AY N. P., DEMİRKAN S. K., RABUŞ Ş., İZZETTİN F. V.
I.Ulusal Eczacılık Eğitimi ve Akreditasyon Kongresi, Ankara, Türkiye, 9 - 10 Mayıs 2016, (Özet Bildiri)

72. KANSER HASTALARINDA İLAÇ KAYNAKLI PROBLEMLERİN BELİRLENMESİNDE KLİNİK ONKOLOJİ ECZACISININ ROLÜ

TEZCAN S., SANCAR M., TURHAL S., YUMUK P., İZZETTİN F. V.
2.Uluslararası İlaç ve Eczacılık Kongresi, 27 - 29 Kasım 2015 Sürdürülebilir Kalkınma

73. Determination of Pharmaceutical Care Needs in Patients with Colon Cancar at An Ambulatory Setting

TEZCAN S., İZZETTİN F. V., SANCAR M., YUMUK P., TURHAL S.
44th ESCP Symposium on Clinical Pharmacy, Lisbon, Portekiz, 28 - 30 Ekim 2015

74. Pharmaceutical Care Impact on Certain Biochemical Levels in Diabetic Cancer Patients

ALTAİAE A., İZZETTİN F. V., SANCAR M., ORÇUN KAPTANAĞASI A.
44th ESCP Symposium on Clinical Pharmacy, Lisbon, Portekiz, 28 - 30 Ekim 2015 Sürdürülebilir Kalkınma

75. Determination of Potentially Drug Drug Interaction in Oncology Patients

ABUNAHLAH N., SANCAR M., DANE F., ÖZYAVUZ M., İZZETTİN F. V.
44th ESCP Symposium on Clinical Pharmacy, Lisbon, Portekiz, 28 Ekim - 30 Kasım 2015

76. Implementation of Medication Reconciliation and Medication Review Services Conducted by Pharmacist in Hospitalized COPD Patients

MAMEDOVA S., SANCAR M., İZZETTİN F. V., DEMİRTUNÇ R., OKUYAN B.
44th ESCP Symposium on Clinical Pharmacy, Lisbon, Portekiz, 28 - 30 Ekim 2015

77. Assessment of Attitude and Knowledge in Patients Utilized Disposable Insulin Pens at Community Pharmacy Setting

OKUYAN B., SEMERCİ Z., ODABAŞI G., İZZETTİN F. V., SANCAR M.
44th ESCP Symposium on Clinical Pharmacy, Lisbon, Portekiz, 28 - 30 Ekim 2015

78. Observation of Dominant Occurence of Radiotherapy Related Acute Side Effects and Management

ALTAİE D., KÖSEOĞLU A., İZZETTİN F. V., TEZCAN S., ALQOZBAKRK T., AKSU A.
44th ESCP Symposium on Clinical Pharmacy, Lisbon, Portekiz, 28 - 30 Ekim 2015

79. Determination of Potential Drug Drug Interactions by Using Various Software Programs at Community Pharmacy Setting

SANCAR M., KAŞIK A., BATUHAN S., BABİ B., İZZETTİN F. V., OKUYAN B.
44th ESCP Symposium on Clinical Pharmacy, Lisbon, Portekiz, 28 - 30 Ekim 2015, (Özet Bildiri)

80. Evaluation of Potentially Inappropriate Medication Use and Drug Burden Index in Elderly Patients with Cancer

PAKSOY C., OKUYAN B., OVEN USTALIOĞLU B., DEMİRTUNÇ R., İZZETTİN F. V., SANCAR M.
44th ESCP Symposium on Clinical Pharmacy, Lisbon, Portekiz, 28 - 30 Ekim 2015 Sürdürülebilir Kalkınma

81. Kışa hazırlıkta bilinmesi gerekenler

İZZETTİN F. V.
Pharmaclass, Türkiye, 3 - 06 Eylül 2015

82. Assessment of medication knowledge among geriatric patients at a community pharmacy setting

OKUYAN B., Duzgun U., Arslan H. I., Sap S., Girgin I., Elmas L., et al.
Symposium of the American-College-of-Clinical-Pharmacy, ELECTR NETWORK, 21 - 22 Mayıs 2013, cilt.33, (Özet Bildiri) identifier

83. The assessment of self-medication utilization in pain management at a community pharmacy setting

OKUYAN B., Atalay M. V., Sahin C., Sahin D., Izzettin F. V., SANCAR M.
Symposium of the American-College-of-Clinical-Pharmacy, ELECTR NETWORK, 21 - 22 Mayıs 2013, cilt.33, (Özet Bildiri) identifier

84. Investigation of Cisplatin Nephrotoxicity in out Patients Using a Short Hydration Method

TEZCAN S., Izzettin F. V., Turhal S.
European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm, İsveç, 23 - 27 Eylül 2011, cilt.47, (Özet Bildiri) identifier

85. Medication use evaluation during acute exacerbation and stable periods in patients with chronic obstructive pulmonary disease

erzen t., SANCAR M., OKUYAN B., İZZETTİN F. V.
ESCP-GSASA 38th Symposium on Clinical Pharmacy, 3 - 06 Kasım 2009, cilt.32

86. A patient drug profile study in acute myocardial infarction

erzen t., SANCAR M., OKUYAN B., İZZETTİN F. V.
ESCP-GSASA 38th Symposium on Clinical Pharmacy, 3 - 06 Kasım 2009, cilt.32
Kitaplar 12

1. İyi Huylu Prostat Büyümesi (İHPH)

İzzettin F. V., Bektay M. Y.
Dipiro Farmakoterapi El Kitabı, Turgay Çelik, Editör, Güneş Kitabevi, İstanbul, ss.941-950, 2022

2. Implementation of Pharmaceutical Care in Oncology

Bektay M. Y., İzzettin F. V.
Oncology Pharmacy Practice: The Clinical Pharmacist’s Perspective, Songul TEZCAN,Mesut SANCAR,Sule RABUS, Editör, NOVA Science Publishers Inc. , New York, ss.91-109, 2021 Sürdürülebilir Kalkınma

3. 8-Hydroxydeoxyguanosine: A Valuable Predictor of Oxidative DNA Damage in Cancer and Diabetes Mellitus

İzzettin F. V., Sancar M.
Cancer Oxidative Stress and Dietary Antioxidants, Victor Preedy,Vinood Patel, Editör, Elsevier Science, Oxford/Amsterdam , Amsterdam, ss.1-596, 2021 Sürdürülebilir Kalkınma

4. Montelukast as Add-On Therapy to Asthma Treatment Improves Symptom Control and Quality of Life

İzzettin F. V., Yıldırım E., Yıldız B. P., Torun B., Sancar M., Anıl B., et al.
The Pharmacological Guide to Montelukast, Søren C. Søren C. Dam, Editör, Nova Science Publishers, New-York, ss.100-163, 2019

5. Benign Prostat Hiperplazisi

İZZETTİN F. V.
FARMAKOTERAPİ EL KİTABI, Barbara Wels, Terry Schwinghammer, Joe DiPiro, Cecily DiPiro, Çeviri Editörü Turgay Çelik, Editör, Güneş Tıb Kitabevleri, İstanbul, ss.867-876, 2019

6. Tiroid Bozuklukları

İZZETTİN F. V., SANCAR M.
FARMAKOTERAPİ EL KİTABI, Barbara Wels, Terry Schwinghammer, Joe DiPiro, Cecily DiPiro, Çeviri Editörü Turgay Çelik, Editör, Güneş Tıp Kitabevleri, İstanbul, ss.192-201, 2019

7. Sedef Hastalığı (Psöriazis)

SANCAR M., İZZETTİN F. V.
Farmakoterapi El Kitabı, Barbara Wels, Terry Schwinghammer, Joe DiPiro, Cecily DiPiro, Çeviri Editörü Turgay Çelik, Editör, Güneş Tıp Kitabevleri, İstanbul, ss.155-163, 2019

8. Gargara Yapma Becerisi

İZZETTİN F. V., SANCAR M.
İlaç Uygulama Becerisi, Prof. Dr. Cengiz Yakıncı, Prof. Dr. Erdem Yeşilada, Editör, Türk Eczacıları Birliği Eczacılık Akademisi, ss.38-39, 2013

9. Assessment of quality of diabetes care for type 2 diabetics.

APIKOGLU-RABUS S., HURSITOGLU M., İZZETTİN F. V., Kiran D.
Advances in Medicine and Biology, Berhardt Leon, Editör, Nova Publishers, Newyork, ss.265-285, 2011

10. Role of the Pharmacist in Blood Glucose Monitoring.

SANCAR M., APIKOGLU-RABUS S., CLARK P. M., İZZETTİN F. V.
Advances in Medicine and Biology, Berhardt Leon, Editör, Nova Science Publishers,, Newyork, ss.287-307, 2011

11. A prospective assessment of therapeutic efficacy and immune effects of levofloxacin and ofloxacin in multiple-drug resistant tuberculosis

CLARK P. M., APIKOGLU-RABUS S., Kiran B., KARAGOZ T., İZZETTİN F. V.
Drug-Resistant Tuberculosis: Causes, Diagnosis and Treatments, S.Nguy, Z.K'ung, Editör, Nova Publishers, New York, ss.237-249, 2009 Sürdürülebilir Kalkınma

12. Türkiye İlaçları

İZZETTİN F. V.
European Drug Index, Muller, Editör, Amsterdam Medical Press, Amsterdam, ss.10, 1996
Metrikler

Yayın

252

Yayın (WoS)

145

Yayın (Scopus)

131

Atıf (WoS)

616

H-İndeks (WoS)

14

Atıf (Scopus)

1006

H-İndeks (Scopus)

16

Atıf (Scholar)

15

H-İndeks (Scholar)

2

Proje

3

Tez Danışmanlığı

12

Açık Erişim

20
BM Sürdürülebilir Kalkınma Amaçları